DHR vs SLB: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and SLB N.V. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
Danaher Corporation Β· Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
SLB N.V. Β· Energy
$56.15
+68.7% upside to fair value
Grade B
QuantHub Verdict
SLB has more upside to fair value (+68.7%). SLB trades at a lower forward P/E (24.3x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DHR SLB
Current Price $174.04 $56.15
Fair Value Estimate $197.01 $94.71
Upside to Fair Value +13.2% +68.7%
Market Cap $123.2B $84.3B
Forward P/E 33.4x 24.3x
EV / EBITDA 20.3x 17.5x
Price / Sales 5.0x 2.4x
Price / FCF 23.3x 17.6x
Revenue Growth YoY +3.7% +2.7%
Gross Margin 60.7% 13.6%
Operating Margin 21.0% 11.5%
Return on Equity 7.1% 12.2%
Dividend Yield 0% 0%
FCF Yield 4.3% 5.69%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
DHR β€” Danaher Corporation
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
SLB β€” SLB N.V.
SLB N.V. is the world's largest oilfield services company operating primarily in the energy sector with a focus on oil and gas equipment and services. The company benefits from a diversified revenue base across well construction, production systems, reservoir characterization, and digital integration, with fiscal year 2024 revenues totaling over $37 billion. Despite modest revenue growth of 2.7% …
Accumulation Zones
Metric DHR SLB
Zone Low $147.76 $71.03
Zone High $167.46 $80.50
In Buy Zone? No Yes
← DHR Research    SLB Research β†’    All Research